Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Share-based Compensation: 2014-2024

Historic Share-based Compensation for AC Immune (ACIU) over the last 11 years, with Dec 2024 value amounting to $6.2 million.

  • AC Immune's Share-based Compensation rose 208.49% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.6 million, marking a year-over-year increase of 42.31%. This contributed to the annual value of $6.2 million for FY2024, which is 26.89% up from last year.
  • Latest data reveals that AC Immune reported Share-based Compensation of $6.2 million as of FY2024, which was up 26.89% from $4.9 million recorded in FY2023.
  • AC Immune's Share-based Compensation's 5-year high stood at $6.2 million during FY2024, with a 5-year trough of $3.5 million in FY2022.
  • Moreover, its 3-year median value for Share-based Compensation was $4.9 million (2023), whereas its average is $4.9 million.
  • Per our database at Business Quant, AC Immune's Share-based Compensation spiked by 57.92% in 2020 and then dropped by 23.45% in 2022.
  • AC Immune's Share-based Compensation (Yearly) stood at $4.5 million in 2020, then declined by 0.15% to $4.5 million in 2021, then declined by 23.45% to $3.5 million in 2022, then surged by 42.36% to $4.9 million in 2023, then increased by 26.89% to $6.2 million in 2024.